Literature DB >> 14314330

COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE.

M Y CHU, G A FISCHER.   

Abstract

Entities:  

Keywords:  ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY; CYTOSINE; DNA, NEOPLASM; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; MAGNESIUM; NUCLEOSIDES; PHARMACOLOGY; PHOSPHOTRANSFERASES; RNA, NEOPLASM; TISSUE CULTURE

Mesh：

Substances：

Year:  1965        PMID： 14314330     DOI： 10.1016/0006-2952(65)90198-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

1.  Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.

Authors:  R L Momparler; N Onetto-Pothier; D Y Bouffard; L F Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

3.  Cytosine-arabinoside does not inhibit incorporation of 3H-thymidine in herpes simplex virus transformed cells.

Authors:  J Roubal
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

Review 4.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Authors:  B A Chabner; D G Johns; C N Coleman; J C Drake; W H Evans
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

6.  Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.

Authors:  V Gandhi; W Plunkett
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Antiviral activity of cytarabine in herpesvirus-infected rats.

Authors:  H E Renis
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

8.  Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia.

Authors:  E R Grümayer; W Schmidmeier; S Panzer; H Gadner
Journal:  Blut       Date:  1986-10

9.  Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.

Authors:  R L Momparler; L F Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

10.  Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors:  M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.